Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;98(4):331-340.
doi: 10.1111/cge.13812. Epub 2020 Aug 2.

Biallelic variants in PPP1R13L cause paediatric dilated cardiomyopathy

H K Robinson  1 , E Zaklyazminskaya  2   3 , I Povolotskaya  3 , Y Surikova  2 , L Mallin  1 , C Armstrong  4 , D Mabin  5 , P J Benke  6   7 , M R Chrisant  6 , M McDonald  8 , C C Marboe  9 , K E Agre  10 , D R Deyle  10 , K McWalter  11 , G Douglas  11 , M S Balashova  3   12 , V Kaimonov  3 , N Shirokova  3 , E Pomerantseva  3 , C L Turner  13 , S Ellard  1   14
Affiliations

Biallelic variants in PPP1R13L cause paediatric dilated cardiomyopathy

H K Robinson et al. Clin Genet. 2020 Oct.

Abstract

Childhood dilated cardiomyopathy (DCM) is a leading cause of heart failure requiring cardiac transplantation and approximately 5% of cases result in sudden death. Knowledge of the underlying genetic cause can aid prognostication and clinical management and enables accurate recurrence risk counselling for the family. Here we used genomic sequencing to identify the causative genetic variant(s) in families with children affected by severe DCM. In an international collaborative effort facilitated by GeneMatcher, biallelic variants in PPP1R13L were identified in seven children with severe DCM from five unrelated families following exome or genome sequencing and inheritance-based variant filtering. PPP1R13L encodes inhibitor of apoptosis-stimulating protein of p53 protein (iASPP). In addition to roles in apoptosis, iASPP acts as a regulator of desmosomes and has been implicated in inflammatory pathways. DCM presented early (mean: 2 years 10 months; range: 3 months-9 years) and was progressive, resulting in death (n = 3) or transplant (n = 3), with one child currently awaiting transplant. Genomic sequencing technologies are valuable for the identification of novel and emerging candidate genes. Biallelic variants in PPP1R13L were previously reported in a single consanguineous family with paediatric DCM. The identification here of a further five families now provides sufficient evidence to support a robust gene-disease association between PPP1R13L and severe paediatric DCM. The PPP1R13L gene should be included in panel-based genetic testing for paediatric DCM.

Keywords: DCM; PPP1R13L; cardio-cutaneous syndrome; iASPP; paediatric dilated cardiomyopathy; progressive heart failure.

PubMed Disclaimer

References

REFERENCES

    1. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296(15):1867-1876. https://doi.org/10.1001/jama.296.15.1867.
    1. Dipchand AI. Current state of pediatric cardiac transplantation. Ann Cardiothorac Surg. 2018;7(1):31-55. https://doi.org/10.21037/acs.2018.01.07.
    1. Bharucha T, Lee KJ, Daubeney PE, et al. Sudden death in childhood cardiomyopathy: results from a long-term national population-based study. J Am Coll Cardiol. 2015;65(21):2302-2310. https://doi.org/10.1016/j.jacc.2015.03.552.
    1. Pahl E, Sleeper LA, Canter CE, et al. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the pediatric cardiomyopathy registry. J Am Coll Cardiol. 2012;59(6):607-615. https://doi.org/10.1016/j.jacc.2011.10.878.
    1. Lee TM, Hsu DT, Kantor P, et al. Pediatric cardiomyopathies. Circ Res. 2017;121(7):855-873. https://doi.org/10.1161/CIRCRESAHA.116.309386.

Publication types

Substances